<DOC>
	<DOC>NCT01375335</DOC>
	<brief_summary>The use of dobutamine in postoperative hemodynamic treatment is widespread despite seemingly intact contraction of the heart. This study aims to elucidate the efficacy of low-dose dobutamine infusion in patients in the postoperative phase replacement of the aortic valve.</brief_summary>
	<brief_title>The Effects of Dobutamine on Postoperative Cardiac Function in Aortic Valve Replacement</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Dobutamine</mesh_term>
	<criteria>1890 years Left ventricular posterior wall =/&gt;12mm Ejection fraction &gt; 45% Sinus rhythm Eligible for aortic valve replacement Need for concomitant cardiac bypass operation. Moderate or severe insufficiency of the mitral valve Active endocarditis Insufficient ultrasound window Using Bblockers Liver insufficiency Patients treated with COMTinhibitors Allergy towards dobutamine Pregnancy Women of fertile age who do not use relevant anticonception Lacking participant consent</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>Postoperative</keyword>
	<keyword>Dobutamine</keyword>
	<keyword>Inotropes</keyword>
	<keyword>Stunning</keyword>
	<keyword>Heart failure</keyword>
</DOC>